Abstract. The effect of hypermagnesaemia on serum levels of immunoreactive calcitonin was studied in normal human subjects. After iv administration of magnesium sulphate over 120 min, the mean (\m=+-\sem) serum magnesium concentration rose from the baseline level of 0.9 \m=+-\0.1 to 2.6 \m=+-\0.3 mmol/l (P < 0.01), and thereafter remained higher than the baseline level. The magnesium infusion caused a significant increase in serum immunoreactive calcitonin levels (P < 0.01). The rise in serum magnesium concentration was accompanied by a significant decrease in the concentrations of corrected serum calcium and whole blood ionized calcium (P < 0.01, P < 0.01, respectively). Our 
panied by a significant decrease in the concentrations of corrected serum calcium and whole blood ionized calcium (P < 0.01, P < 0.01, respectively). Our results suggest that hypermagnesaemia causes an increase in serum immunoreactive calcitonin levels in normal human subjects despite a decrease in the concentrations of corrected serum calcium and whole blood ionized calcium.
Although calcium is the principal regulator of the thyroid C-cell function, magnesium has also been observed to have an important role. All reports of in vitro and in vivo animal studies indicate that magnesium, like calcium, stimulates the release of calcitonin (CT) from the thyroid gland (Radde et al. 1969; Bell 1970; Care et al. 1971 ; Littledike & Arnaud 1971) . However, the effect of hypermagnesaemia on serum CT has not been extensively studied in normal human subjects. Some investi¬ gators demonstrated no significant change of se¬ rum immunoreactive CT (iCT) levels during mag¬ nesium infusion in pre-eclamptic women (Cruikshank et al. 1979) , whereas others found a marked increased level of serum iCT during magnesium administration (Deftos et al. 1978) . On the other hand, Anast et al. (1975) 
Results
The results of magnesium infusion are shown in mal baseline levels of 0.9 ± 0.1 to 2.6 ± 0.3 mmol/1 (P < 0.01) at 120 min, and thereafter remained higher than the baseline level up to 270 min (Fig.  1A) . The magnesium infusion caused a significant increase in serum iCT levels (P < 0.01). The se¬ rum iCT level increased significantly from the baseline level of 43.7 ± 5.4 to 60.0 ± 7.0 ng/l (P < 0.01) at 150 min and to 54.0 ± 8.2 ng/l (P < 0.05) at 210 min (Fig. IB) (Suzuki et al. 1986 ). How¬ ever, the role of CT in the development of hypo¬ calcaemia associated with hypermagnesaemia re¬ mains unclear. CT has previously been reported as the major factor responsible for the hypocalcaemic effect of magnesium in animal studies (Radde et 
